Four versus 3 Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathological Response and Survival-Reference-Cited by-同舟云学术

Four versus 3 Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathological Response and Survival

Published:2022-01 Issue:1 Volume:207 Page:77-85
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Patel Hiten D.¹^ORCID,Patel Sunil H.²,Blanco-Martinez Enrique¹,Kuzbel Jake²,Chen Victor S.,Druck Aleksander¹,Koehne Elizabeth L.¹,Patel Parth M.¹,Doshi Chirag P.¹,Hahn Noah M.²³,Hoffman-Censits Jean H.²³,Berg Stephanie⁴,Bivalacqua Trinity J.²,Kates Max²,Quek Marcus L.¹

Affiliation:

1. Department of Urology, Loyola University Medical Center, Maywood, Illinois

2. The James Buchanan Brady Urologic Institute and Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland

3. Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

4. Division of Hematology/Oncology, Loyola University Medical Center, Maywood, Illinois

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival outcomes in patients with muscle-invasive bladder cancer receiving neoadjuvant chemotherapy stratified by number of cycles;Clinical Genitourinary Cancer;2024-09

2. Recent Advances of Neoadjuvant Immunotherapy for Urothelial Bladder Cancer;Annals of Surgical Oncology;2024-07-12

3. Don’t throw out the baby with the bath water!;Scandinavian Journal of Urology;2024-05-20

4. The optimal number of induction chemotherapy cycles in clinically lymph node‐positive bladder cancer;BJU International;2024-03-12

5. Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle-Invasive Bladder Cancer: Elective and Eligibility Factors Impacting Utilization;Urology Practice;2024-01